Activest Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Sell
8,877
-15,944
-64% -$417K 0.04% 121
2026
Q1
$697K Buy
24,821
+7,104
+40% +$189K 0.12% 73
2025
Q4
$441K Sell
17,717
-7,098
-29% -$179K 0.08% 98
2025
Q3
$632K Buy
24,815
+4,293
+21% +$106K 0.13% 68
2025
Q2
$497K Buy
20,522
+15,240
+289% +$355K 0.12% 67
2025
Q1
$134K Buy
5,282
+1,530
+41% +$40K 0.04% 113
2024
Q4
$99.5K Sell
3,752
-403
-10% -$10.9K 0.03% 123
2024
Q3
$120K Buy
4,155
+2,253
+118% +$65.7K 0.04% 108
2024
Q2
$53.2K Buy
1,902
+28
+1% +$771 0.02% 161
2024
Q1
$52K Sell
1,874
-1,041
-36% -$28.9K 0.03% 111
2023
Q4
$83.9K Buy
2,915
+1,094
+60% +$33.1K 0.05% 64
2023
Q3
$60.4K Buy
+1,821
New +$64.4K 0.04% 82
2022
Q1
Sell
-500
Closed -$30K 363
2021
Q4
$30K Sell
500
-262
-34% -$13K 0.02% 138
2021
Q3
$33K Sell
762
-651
-46% -$28.8K 0.02% 137
2021
Q2
$55K Sell
1,413
-56
-4% -$2.18K 0.04% 97
2021
Q1
$53K Buy
+1,469
New +$52.2K 0.04% 97

Other funds holding PFE

Activest Wealth Management's PFE Position: Q2 2026 in Review

Activest Wealth Management reduced its Pfizer (PFE) stake by 64% in Q2 2026, selling an estimated $417K and leaving 8,877 shares worth $214K. The position accounts for 0.04% of the portfolio, ranked #121.

Activest Wealth Management first reported a position in PFE in Q1 2021 and has held it in 16 quarters since. The position peaked at $697K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Activest Wealth Management held 8,877 shares of Pfizer worth $214K as of Q2 2026.
  • Activest Wealth Management sold 15,944 Pfizer shares in Q2 2026, an estimated $417K.
  • Pfizer made up 0.04% of Activest Wealth Management's portfolio in Q2 2026, its #121 holding.
  • Activest Wealth Management first reported a position in Pfizer in Q1 2021 and has held it in 16 quarters since.
  • Activest Wealth Management's Pfizer position peaked at $697K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.